Allspring Global Investments Holdings, LLC Intra Cellular Therapies, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 69,696 shares of ITCI stock, worth $5.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
69,696
Previous 16,374
325.65%
Holding current value
$5.03 Million
Previous $1.13 Million
321.27%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ITCI
# of Institutions
399Shares Held
87.1MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$694 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$457 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$269 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$248 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$217 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.82B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...